Bakker Juliet Tammenoms - Jun 6, 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 04:07 PM
Previous filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Award +2.55K +7.33% 37.4K Jun 6, 2024 Direct F1, F2
holding RXST Common Stock 1.55K Jun 6, 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
F2 Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 6, 2024.
F3 These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.